Co-administration of eribulin and farletuzumab for the treatment of breast cancer
AssigneeMorphotek, Inc.
InventorJulia D. Maltzman
Life of this patent
Estimating the term…
Loading patent…
AssigneeMorphotek, Inc.
InventorJulia D. Maltzman
Estimating the term…
A method for transmission network control, the transmission network being configured for use in providing electricity from a generator to an end user, the method including receiving a sensitivity parameter, identifying a switchable set of switches within the transmission network using the sensitivity parameter, determining a candidate switch from the switchable set to change a corresponding state, wherein the state can be changed from open to closed and closed to open, determining a proposed change of state of the candidate switch, updating an optimal power flow (OPF) problem as a function of the candidate switch and the proposed change of state, determining and storing in a memory a solution to the updated OPF problem, generating an updated sensitivity parameter based on the stored solution to the updated OPF problem, and determining, using the updated sensitivity parameter, if the stored solution to the updated OPF problem meets a predetermined criterion.
A method of treating a subject suffering from breast cancer, the method comprising:
3-4. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
31-32. (canceled)
(canceled)
37-40. (canceled)
A method of treating a subject suffering from breast cancer, the method comprising:
A method of treating a subject suffering from breast cancer, the method comprising:
Dependencies are inferred from the claim text.